Mehta, R. S., Bassett, R., Olson, A., Chen, J., Ahmed, S., Alousi, A. M., Anderlini, P., Al-Atrash, G., Bashir, Q., Ciurea, S. O., Hosing, C. M., Im, J. S., Kebriaei, P., Khouri, I., Marin, D., Molldrem, J. J., Nieto, Y., Oran, B., Rezvani, K., Qazilbash, M. H., Srour, S. A., Shpall, E. J., Andersson, B. S., Champlin, R. E. and Popat, U. R. (2019) “Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial”, Haematologica. Pavia, Italy, 104(12), pp. e555-e557. doi: 10.3324/haematol.2018.214429.